AU2001285042A1 - Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor - Google Patents

Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor

Info

Publication number
AU2001285042A1
AU2001285042A1 AU2001285042A AU8504201A AU2001285042A1 AU 2001285042 A1 AU2001285042 A1 AU 2001285042A1 AU 2001285042 A AU2001285042 A AU 2001285042A AU 8504201 A AU8504201 A AU 8504201A AU 2001285042 A1 AU2001285042 A1 AU 2001285042A1
Authority
AU
Australia
Prior art keywords
peripheral
methods
cell lymphoma
histone deacetylase
deacetylase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285042A
Inventor
Susan E. Bates
Antonio T. Fojo
Richard Piekarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
GOVERNEMENT OF UNITED STAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOVERNEMENT OF UNITED STAT filed Critical GOVERNEMENT OF UNITED STAT
Publication of AU2001285042A1 publication Critical patent/AU2001285042A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001285042A 2000-08-18 2001-08-17 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor Abandoned AU2001285042A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22623400P 2000-08-18 2000-08-18
US60/226,234 2000-08-18
PCT/US2001/025827 WO2002015921A2 (en) 2000-08-18 2001-08-17 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor

Publications (1)

Publication Number Publication Date
AU2001285042A1 true AU2001285042A1 (en) 2002-03-04

Family

ID=22848093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285042A Abandoned AU2001285042A1 (en) 2000-08-18 2001-08-17 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor

Country Status (2)

Country Link
AU (1) AU2001285042A1 (en)
WO (1) WO2002015921A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003032921A2 (en) 2001-10-16 2003-04-24 Sloan-Kettering Institute For Cancer Research Treatment of neurodegenerative diseases and cancer of the brain
US7456219B2 (en) 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid
ES2532607T3 (en) 2002-03-04 2015-03-30 Merck Hdac Research, Llc Induction methods of terminal differentiation
US7148257B2 (en) 2002-03-04 2006-12-12 Merck Hdac Research, Llc Methods of treating mesothelioma with suberoylanilide hydroxamic acid
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
WO2006094068A2 (en) 2005-03-01 2006-09-08 The Regents Of The University Of Michigan Hdac inhibitors that promote brm expression and brm related diagnostics
TWI365068B (en) 2005-05-20 2012-06-01 Merck Sharp & Dohme Formulations of suberoylanilide hydroxamic acid and methods for producing same
CN101263121A (en) 2005-07-14 2008-09-10 塔克达圣地亚哥公司 Histone deacetylase inhibitors
US20100137239A1 (en) 2006-04-24 2010-06-03 Gloucester Pharmaceuticals Gemcitabine combination therapy
WO2007146730A2 (en) 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
CA2654936A1 (en) * 2006-06-28 2008-01-03 Novartis Ag Use of hdac inhibitors for the treatment of lymphomas
GB0620823D0 (en) 2006-10-19 2006-11-29 Univ London Histone deacetylase inhibitors
AU2007342028B2 (en) 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
RU2607634C2 (en) * 2010-07-12 2017-01-10 Селджин Корпорейшн Romidepsin solid forms and use thereof
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
CN103442715A (en) * 2011-03-21 2013-12-11 瓦尔库里亚公司 A pharmaceutical composition comprising an HDAC inhibitor and a steroid and the use thereof.
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124495A (en) * 1997-03-11 2000-09-26 Beacon Laboratories, Inc. Unsaturated oxyalkylene esters and uses thereof

Also Published As

Publication number Publication date
WO2002015921A2 (en) 2002-02-28
WO2002015921A3 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2001285042A1 (en) Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
AU2002243402A1 (en) Inhibitors of histone deacetylase
AU2001298014A1 (en) Inhibition of specific histone deacetylase isoforms
AU2001282886A1 (en) Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
IL148497A0 (en) Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
HK1057746A1 (en) Hydroxamate derivatives useful as deacetylase inhibitors
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2002309523A1 (en) A brachytherapy device and method of use
AU2003209202A1 (en) Method and device to treat vulnerable plaque
HUP0400668A3 (en) Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof
AU2003286249A1 (en) Histone deacetylase inhibitors
WO2001085201A3 (en) Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
GB0005199D0 (en) Modulation of histone deacetylase
AU2003243298A1 (en) Gaming device and methods of use
AU2002212350A1 (en) Regulation of human histone deacetylase
AU2002315229A1 (en) Histone deacetylase and methods of use thereof
EP1408946A4 (en) Histone deacetylase inhibitors
AU2003299815A1 (en) Matriptase inhibitors and methods of use
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU2002215018A1 (en) Human histone deacetylase gene
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU2003294110A1 (en) Use of a histone deacetylase inhibitor for treating muscular dystrophies
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002225915A1 (en) Antisense modulation of histone deacetylase 1 expression